RedCarpetLife
1022
In the world today
Willy Michel

Willy Michel

W. Michel
-0.34% | - $-14.18M
$4.19 B ₹ 38,401 Cr
Real Time Net Worth #1022 Ranking as of 01 Mar 2026 By Forbes

More on Willy Michel

Gender

Male

Age

78Y

Country

Switzerland

Born On

July, 1947

Deceased

No

Relationship Status

Married

Children

2

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Medical Devices)

Primary Organization

Ypsomed

Titles

Founder & Chairman Emeritus

Sources of Wealth

Ypsomed

Industry

Medical Devices, Healthcare, Manufacturing

About Willy Michel


W illy Michel is a self-made Swiss billionaire who built his fortune in the medical technology industry. In the 1970s, he co-founded a company that developed and manufactured medical injection systems. His first major success came in 2004 when he sold his stake in that company to the pharmaceutical giant Sanofi-Aventis for over a billion dollars. This deal provided him with the capital for his next and even more successful venture.

He had previously founded a second company, Ypsomed, which focused on the development and manufacturing of self-injection devices, such as insulin pens for diabetics and autoinjectors for other medications. After his first company was sold, he bought back a division of it and merged it into Ypsomed, which he has since built into a global leader in its field. He took the company public on the Swiss stock exchange, and his large controlling stake is the primary source of his wealth. He is also the owner of the historic St. Ursus Cathedral in Solothurn, which he helped to restore.

Advertisement

Quick Reads


  • Founder of the medical device company Ypsomed.
  • Ypsomed is a leading global producer of self-injection devices like insulin pens.
  • Made his first fortune selling a different medical technology company to Sanofi-Aventis.
  • He is a self-made billionaire.
  • His company is publicly traded in Switzerland.

Early Life and Background


Willy Michel is a Swiss businessman, the self-made billionaire Founder and Executive Chairman of Ypsomed AG (SIX: YPSN), a global leader in medical device technology specializing in injection systems for self-medication (e.g., insulin pens). His career is rooted in medical technology, engineering, and entrepreneurial audacity.

Michel's philosophical approach centers on scale, technological excellence, and long-term commitment to private healthcare solutions (pioneering the modern insulin pen and self-medication device model). He founded the precursor to Ypsomed in 1984.

  • Ypsomed AG (Founder & Executive Chairman): The core publicly traded asset, a global leader in injection and infusion systems for pharmaceuticals (specializing in diabetes and autoimmune diseases).
  • Medical Pioneer: His success is built on scale manufacturing and dominating the domestic and international market for specialized drug delivery devices.
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive global growth of self-medication and chronic disease management.

Career Journey of Willy Michel


Willy Michel's strategic genius was his commitment to high-precision engineering. He founded Ypsomed (originally Disetronic) in 1984, successfully building it into a global force by pioneering innovative drug delivery systems. His structural contribution is immense: pioneering the scale manufacturing and professionalization of the specialized medical device sector, providing essential tools for chronic disease management. The company successfully executed its IPO on the SIX Swiss Exchange (SIX).

He remains Executive Chairman, guiding the company's continuous expansion and technological modernization. His wealth is secured by the colossal, long-term, stable profitability of the global medical device and technology sector.

Advertisement

Willy Michel's Timeline


1984:

Founds the precursor to Ypsomed (Disetronic) (Founding).

1999 (approx.):

Ypsomed executes its successful IPO on the SIX Swiss Exchange (Financial Milestone).

2000s:

Ypsomed expands aggressively into global markets (Global Expansion Apex).

Ongoing:

Continues as Founder and Executive Chairman, guiding the global technology giant (Executive Oversight).

Major Business Ventures and Investments


Willy Michel's wealth is concentrated in his founding equity and continued executive leadership of the publicly traded technology giant, Ypsomed AG (SIX: YPSN), and his private investments.

  • Ypsomed AG (Founder & Executive Chairman): The core publicly traded asset, a global leader in injection and infusion systems.
  • Medical Pioneer: His success is built on scale manufacturing and dominating the domestic and international market for specialized drug delivery devices.
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive global growth of self-medication and chronic disease management.

Advertisement

Philanthropy and Social Impact


Willy Michel's social impact stems from Ypsomed's role in providing essential, high-precision medical devices that enable self-medication for chronic diseases like diabetes, significantly improving patient care and quality of life globally. His personal philanthropy supports various community and educational initiatives, often focused on medical research and technological education.

His personal philanthropy supports various community and educational initiatives.

Fashion, Style, and Lifestyle


Willy Michel maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects serious authority and stability, typical of a leader in the global medical technology sector.

Residing in Burgdorf, Switzerland, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to technology innovation, strategic management, and industrial scale.

Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is the Founder and Executive Chairman of Ypsomed (injection systems for self-medication).
  • Ypsomed is a global leader in insulin pens and autoinjectors.
  • He founded the original company in 1984.
  • His fortune is tied to the successful monetization and scale of the specialized medical device sector.
  • His philosophy emphasizes technological excellence and long-term R&D.

Advertisement

More Profiles


Beatriz Davila de Santo Domingo

+0.63% | +$32.31M

Ding Shizhong

-1.38% | -$103.05M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content